**Earnings Highlights for Alnylam Pharmaceuticals Inc. (ALNY):**
**Earnings:** Alnylam Pharmaceuticals Inc. reported a loss of $16.889 million in the second quarter, compared to a loss of $276.024 million in the same period last year. **EPS (Earnings Per Share):** The company’s earnings per share improved to -$0.13 in Q2, from -$2.21 in the same quarter last year. Excluding certain items, the adjusted earnings for the period amounted to $73.766 million, or $0.56 per share.
**Projections:** Analysts had projected an earnings per share of -$1.08. **Revenue:** The revenue for the second quarter surged to $659.825 million, up from $318.754 million in the corresponding period last year.
